Tag Archives: patients

FDA Approves Fotivda (tivozanib) for the Treatment of Adult Patients with Relapsed or Refractory Advanced Renal Cell Carcinoma

FDA Approves Fotivda (tivozanib) for the Treatment of Adult Patients with Relapsed or Refractory Advanced Renal Cell Carcinoma BOSTON–(BUSINESS WIRE) March 10, 2021 — AVEO Oncology (Nasdaq: AVEO) today announced that the U.S. Food and Drug Administration (FDA) has approved Fotivda (tivozanib) for the treatment of adults with relapsed or refractory advanced renal cell carcinoma… Read More »

FDA Approves Nulibry (fosdenopterin) to Reduce the Risk of Mortality in Patients with Molybdenum Cofactor Deficiency (MoCD) Type A

FDA Approves Nulibry (fosdenopterin) to Reduce the Risk of Mortality in Patients with Molybdenum Cofactor Deficiency (MoCD) Type A PALO ALTO, February 28, 2021 – BridgeBio Pharma, Inc. (Nasdaq: BBIO) (BridgeBio) and affiliate Origin Biosciences, Inc. (Origin) today announced the U.S. Food and Drug Administration (FDA) has approved Nulibry (fosdenopterin) for Injection as the first… Read More »

Telehealth’s uncertain future raises alarm bells for cancer patients

The relaxation of telehealth regulations in response to the COVID-19 pandemic has triggered a wave of interest and support, with patients noting the convenience, discretion and safety of virtual care as major selling points. But another, perhaps less publicized advantage of telemedicine is the availability of specialists for patients – particularly those with chronic… Read More »

John Ivison: The math of saving lives — Canada’s drug battle leaves patients caught in the middle

Article content continued We feel that everyone is blaming someone else and patients are caught in the middle Vertex has done spectacularly well from Trikafta this year, reporting sales of US$ 918 million in second quarter of this year, from zero last year. That helped the company’s net income to soar 213 per cent year… Read More »